KEGG   PATHWAY: oki04115
Entry
oki04115                    Pathway                                
Name
p53 signaling pathway - Oncorhynchus kisutch (coho salmon)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
oki04115  p53 signaling pathway
oki04115

Organism
Oncorhynchus kisutch (coho salmon) [GN:oki]
Gene
109864549  [KO:K10151]
109864759  [KO:K10141]
109865358  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109866278  sesn1; sestrin-1 isoform X1 [KO:K10141]
109866447  [KO:K16857]
109866461  rrm2; ribonucleoside-diphosphate reductase subunit M2 [KO:K10808] [EC:1.17.4.1]
109866923  [KO:K08738]
109866944  [KO:K04398] [EC:3.4.22.61]
109867112  [KO:K04726]
109867280  [KO:K10151]
109867486  [KO:K04506] [EC:2.3.2.27]
109867514  [KO:K04503]
109867955  [KO:K05868]
109868291  [KO:K10146]
109868307  [KO:K04722]
109868689  [KO:K04402]
109868714  [KO:K04402]
109868902  [KO:K10128]
109869105  [KO:K10142] [EC:1.16.1.-]
109869528  [KO:K04570]
109869567  casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
109869671  [KO:K26543]
109870106  [KO:K10136]
109870175  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109870629  [KO:K04398] [EC:3.4.22.61]
109870995  [KO:K08738]
109871927  cop1; E3 ubiquitin-protein ligase COP1 isoform X1 [KO:K10143] [EC:2.3.2.27]
109872257  [KO:K04402]
109872299  [KO:K04722]
109872345  [KO:K10138]
109872356  [KO:K04398] [EC:3.4.22.61]
109872357  [KO:K04398] [EC:3.4.22.61]
109872384  [KO:K02161]
109872777  [KO:K10134]
109872804  [KO:K10147] [EC:3.1.3.16]
109873031  tp53; cellular tumor antigen p53 isoform X2 [KO:K04451]
109873941  [KO:K04722]
109874104  [KO:K04402]
109874105  [KO:K04402]
109874313  [KO:K05868]
109874805  [KO:K10143] [EC:2.3.2.27]
109874825  [KO:K02161]
109875313  [KO:K04402]
109875672  [KO:K10141]
109875865  [KO:K10136]
109875991  [KO:K10146]
109876183  [KO:K06641] [EC:2.7.11.1]
109877000  [KO:K10144] [EC:2.3.2.27]
109877226  [KO:K10146]
109877885  [KO:K06509]
109878161  [KO:K10142] [EC:1.16.1.-]
109878332  [KO:K10145]
109878550  [KO:K02084]
109878706  [KO:K16857]
109878903  tsc2; LOW QUALITY PROTEIN: tuberin [KO:K07207]
109879117  [KO:K06625]
109879493  ccng1; cyclin-G1 [KO:K10145]
109880007  [KO:K04398] [EC:3.4.22.61]
109880441  [KO:K10135]
109880450  [KO:K03982]
109880954  [KO:K10147] [EC:3.1.3.16]
109881514  chek1; serine/threonine-protein kinase Chk1 [KO:K02216] [EC:2.7.11.1]
109881734  [KO:K06509]
109882220  [KO:K02187] [EC:3.4.22.56]
109882619  [KO:K02089] [EC:2.7.11.22]
109882628  [KO:K02206] [EC:2.7.11.22]
109882975  [KO:K02084]
109883147  [KO:K04402]
109883676  [KO:K10151]
109883840  pidd1; LOW QUALITY PROTEIN: p53-induced death domain-containing protein 1 [KO:K10130]
109884023  atr; serine/threonine-protein kinase ATR [KO:K06640] [EC:2.7.11.1]
109885077  ddb2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
109885786  [KO:K02159]
109885836  [KO:K04503]
109885926  [KO:K06643] [EC:2.3.2.27]
109885927  [KO:K06643] [EC:2.3.2.27]
109886072  [KO:K06626]
109886907  [KO:K06509]
109887808  [KO:K21770]
109888736  [KO:K06509]
109889097  [KO:K04402]
109889311  [KO:K04506] [EC:2.3.2.27]
109889568  [KO:K10151]
109889644  [KO:K04503]
109889859  aifm2; apoptosis-inducing factor 2 [KO:K22745]
109889949  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109889950  [KO:K04390]
109890002  [KO:K02087] [EC:2.7.11.22 2.7.11.23]
109890126  [KO:K08738]
109890231  [KO:K26543]
109890954  [KO:K04570]
109891067  mdm4; protein Mdm4 isoform X1 [KO:K10127]
109891102  [KO:K10152]
109891106  [KO:K06625]
109891461  [KO:K10135]
109892645  [KO:K10141]
109892717  [KO:K10134]
109893143  [KO:K02159]
109893282  [KO:K02091] [EC:2.7.11.22]
109893341  [KO:K02159]
109893357  [KO:K02159]
109894209  [KO:K02187] [EC:3.4.22.56]
109894521  [KO:K16857]
109894540  [KO:K22744]
109894563  [KO:K02206] [EC:2.7.11.22]
109894658  [KO:K02089] [EC:2.7.11.22]
109895006  [KO:K05868]
109895385  ccnb2; G2/mitotic-specific cyclin-B2 isoform X1 [KO:K21770]
109895467  [KO:K04503]
109895481  [KO:K06626]
109895513  [KO:K02159]
109895648  chek2; serine/threonine-protein kinase Chk2 [KO:K06641] [EC:2.7.11.1]
109895712  [KO:K10144] [EC:2.3.2.27]
109895721  [KO:K10146]
109895790  [KO:K26543]
109895960  [KO:K06625]
109896106  [KO:K04722]
109896151  [KO:K04402]
109896659  igf1; insulin-like growth factor I isoform X1 [KO:K05459]
109896674  [KO:K05459]
109896687  [KO:K10151]
109896771  [KO:K06625]
109896857  [KO:K03982]
109897084  [KO:K04451]
109897410  [KO:K10151]
109897545  [KO:K02159]
109897761  gtse1; G2 and S phase-expressed protein 1 [KO:K10129]
109897764  [KO:K04570]
109897962  [KO:K10137]
109898068  [KO:K04402]
109898102  [KO:K10138]
109899109  [KO:K04390]
109899300  [KO:K02161]
109899723  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
109899760  [KO:K02087] [EC:2.7.11.22 2.7.11.23]
109900601  [KO:K10808] [EC:1.17.4.1]
109901007  [KO:K10141]
109901037  [KO:K02187] [EC:3.4.22.56]
109901437  adgrb1; adhesion G protein-coupled receptor B1 [KO:K04596]
109901970  [KO:K06626]
109902355  [KO:K04402]
109902467  [KO:K10128]
109902765  [KO:K04402]
109902873  gorab; RAB6-interacting golgin [KO:K19748]
109902988  zmat3; zinc finger matrin-type protein 3 isoform X2 [KO:K10137]
109903300  [KO:K10808] [EC:1.17.4.1]
109903749  [KO:K04596]
109904001  [KO:K22744]
109904020  [KO:K16857]
109904320  tp53i3; quinone oxidoreductase PIG3 [KO:K10133] [EC:1.-.-.-]
109904398  [KO:K02091] [EC:2.7.11.22]
109905000  [KO:K02187] [EC:3.4.22.56]
109905173  [KO:K10141]
109905879  cntd2; cyclin N-terminal domain-containing protein 2 [KO:K21770]
109906265  [KO:K04451]
109906949  [KO:K04596]
109907201  [KO:K02091] [EC:2.7.11.22]
109907331  [KO:K20394]
109907899  tp73; tumor protein p73 isoform X1 [KO:K10148]
109907974  [KO:K04570]
109908176  [KO:K06626]
109908435  [KO:K08738]
109908593  [KO:K26543]
109909170  atm; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
109909512  ppp1r13l; relA-associated inhibitor [KO:K27356]
109909828  [KO:K02161]
116353052  [KO:K10138]
116361828  [KO:K06509]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
oki04110  Cell cycle
oki04210  Apoptosis
oki04218  Cellular senescence
KO pathway
ko04115   

DBGET integrated database retrieval system